Mark Liebow
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 9
-
- Epigenetics and DNA Methylation 2
- Co-authors
- Zachary S. Fredericksen (18 shared papers)James R. Cerhan (21 shared papers)Susan L. Slager (20 shared papers)Alice H. Wang (14 shared papers)Thomas M. Habermann (17 shared papers)Timothy G. Call (15 shared papers)Julie M. Cunningham (12 shared papers)Stephen M. Ansell (12 shared papers)
- Journals
- Cancer Epidemiology Biomarkers & Prevention (5 papers)Mayo Clinic Proceedings (5 papers)Journal of General Internal Medicine (4 papers)Cancer Research (3 papers)International Journal of Cancer (3 papers)
- Partner nations
- United StatesBelarusVietnam
In The Last Decade
Mark Liebow
44 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 112
- Pathology and Forensic Medicine 185
- Genetics 94
- Health Informatics 12
- Immunology 170
- Family Practice 13
Countries citing papers authored by Mark Liebow
This map shows the geographic impact of Mark Liebow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Liebow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Liebow more than expected).
Fields of papers citing papers by Mark Liebow
This network shows the impact of papers produced by Mark Liebow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Liebow. The network helps show where Mark Liebow may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Liebow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 187 | |
| 2 | 2013 | 153 | |
| 3 | 2007 | 119 | |
| 4 | 2015 | 99 | |
| 5 | 2002 | 75 | |
| 6 | 2002 | 63 | |
| 7 | 2008 | 57 | |
| 8 | 2009 | 54 | |
| 9 | 2008 | 50 | |
| 10 | 2005 | 47 | |
| 11 | 2010 | 47 | |
| 12 | 2002 | 44 | |
| 13 | 2008 | 37 | |
| 14 | 2011 | 36 | |
| 15 | 2012 | 35 | |
| 16 | 2010 | 34 | |
| 17 | 2013 | 32 | |
| 18 | Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma. | 2011 | 31 |
| 19 | 2018 | 27 | |
| 20 | 2020 | 26 |
About Mark Liebow
Mark Liebow is a scholar working on Pathology and Forensic Medicine, Molecular Biology, Public Health, Environmental and Occupational Health, Immunology and Cancer Research, having authored 44 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (4 papers), Ovarian cancer diagnosis and treatment (3 papers), Healthcare cost, quality, practices (3 papers), Innovations in Medical Education (3 papers), Healthcare Policy and Management (2 papers), Epigenetics and DNA Methylation (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (185 citations), Genetics (94 citations), Health Informatics (12 citations), Immunology (170 citations) and Family Practice (13 citations). Mark Liebow has collaborated with scholars based in United States, Belarus and Vietnam. Frequent co-authors include Zachary S. Fredericksen, James R. Cerhan, Susan L. Slager, Alice H. Wang, Thomas M. Habermann, Timothy G. Call, Julie M. Cunningham, Stephen M. Ansell, Eric S. Edell and Maurits J. Wiersema. Their work appears in journals such as Cancer Epidemiology Biomarkers & Prevention, Mayo Clinic Proceedings, Journal of General Internal Medicine, Cancer Research and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.